Memantine Hydrochloride Tablet, Film Coated
Product Images NDC 55154-4151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 55154-4151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

2815463f 49a5 4573 A623 Ccce40d5f459 00

2815463f 49a5 4573 A623 Ccce40d5f459 00
This is a bottle of memantine hydrochloride tablets, USP 10 mg, with NDC 55154-7637-0. The bottle contains 10 tablets, and each tablet contains 10 mg of memantine hydrochloride USP. The usual dosage and storage instructions are included. The product insert for dosing and full prescribing information, precautions, and warnings can be found at www.majorpharmaceuticals.com. This unit dose package is not child-resistant and is intended for institutional use only. Keep out of reach of children, and dispense tightly closed in a container described in the USP. The package is distributed by Major Pharmaceuticals and Cardinal Health.*
FDA Label Image

2815463f 49a5 4573 A623 Ccce40d5f459 01

2815463f 49a5 4573 A623 Ccce40d5f459 01
This is a description of Memantine Hydrochloride tablets, USP 5mg, produced by Dr. Reddy's Laboratories Limited and distributed by Major® Pharmaceuticals. The tablets are typically used to treat memory loss and confusion in people with Alzheimer's disease. The packaging contains important information about dosing and side effects, and it is only available through prescription. It is recommended to store the tablets at 20°-25°C, and to keep them out of reach of children. This description also includes information on the package restrictions, and it instructs to dispense the tablets with a patient information sheet.*
FDA Label Image

Figure1

Figure1
FDA Label Image

Figure2

Figure2
FDA Label Image

Figure3

Figure3
FDA Label Image

Figure4

Figure4
FDA Label Image

Figure5

Figure5
FDA Label Image

Figure6

Figure6
FDA Label Image

Figure7

Figure7
FDA Label Image

Figure8

Figure8
FDA Label Image

Structure

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.